Non-Analgesic Effects of Opioids: Management of Opioid-Induced Constipation by Peripheral Opioid Receptor Antagonists: Prevention or Withdrawal?

By  

Current Pharmaceutical Design, Vol. 18, Iss. 37, 2012-12 ,pp. : 6010-6020

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Propofol-Induced Injection Pain by Sufentanil: A Placebo-Controlled Comparison with Remifentanil

By Honarmand Azim   Safavi Mohammadreza  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 27-35

Adis International

Access to resources Recommend Favorite

A Comparison of Midazolam with Remifentanil for the Prevention of Myoclonic Movements Following Etomidate Injection

By Hwang J-Y   Kim J-H   Oh A-Y   Do S-H   Jeon Y-T   Han S-H  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 17-22

Field House Publishing

Access to resources Recommend Favorite

Bolus Effective Dose of Ketamine for Preventing Withdrawal Movement on Injection of Rocuronium in Paediatric Patients

By Min SK   Lee SY   Park KS   Yoo J   Chae YJ  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1408-1412

Field House Publishing

Access to resources Recommend Favorite

An evidence based systematic review of remifentanil associated opioid-induced hyperalgesia

By Rivosecchi Ryan M   Rice Mark J   Smithburger Pamela L   Buckley Mitchell S   Coons James C   Kane-Gill Sandra L  

Expert Opinion on Drug Safety, Vol. 13, Iss. 5, 2014-05 ,pp. : 587-603

Informa Healthcare

Access to resources Recommend Favorite